NRX:TSXV, NurExone Biologic Inc.

NRX stock overview

NurExone Biologic Inc. (NRX:TSXV) closed at $0.550 on October 22, 2026, up 1.85% on the day. The stock trades 27.6% below its 52-week high of $0.760 and 26.4% above its 52-week low of $0.435. Over the past year, it lost 26.7%. NurExone Biologic Inc. is part of the Health Care sector.

Key figures

Price
$0.550
Day change
+1.85%
Volume
6,001
Average volume
22,363
Market cap
50M+
52-week range
$0.435 – $0.760
50-day average
$0.593
200-day average
$0.598

Price action over the past year

In 252 trading sessions since October 22, 2025, NRX closed higher on 76 days (30%). Its best day was August 18, 2026 (+26.32%) and its worst was September 28, 2026 (-13.43%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

NRX news

About NurExone Biologic Inc.

NurExone Biologic Inc is engaged in the in development of novel, biologic and minimal-invasive treatment for Spinal Cord Injury and Traumatic Brain Injury.

Similar stocks

Find more stocks like NRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.